WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff Relief: ... Chinese pharma firms may have escaped the immediate impact of U.S. President Donald Trump's newly announced 100% tariff on patented drugs, but longer-term threats from Wa...
(9/30/2025)

China's Innovative Drug Sector Secures Over CN... (10/13/2025)

Challenges and Opportunities in Oncology Drug ... (9/23/2025)

China's Edge over U.S. Biotech Was Never Scien... (9/23/2025)

China's Role in Global Drug Approvals Expands ... (9/22/2025)

PRC Consolidates Pharmaceutical Supply Chain D... (9/19/2025)

China Biopharma at Crossroads: A... (9/19/2025)

Gottlieb Cautions Blanket China Drug Licensing... (9/19/2025)

Obesity in China (The Lancet) (9/19/2025)

China's Biotechs Navigate the Demands of Inter... (9/19/2025)

On the Cusp of a Cure: Is Asia Pacific Ready f... (9/18/2025)

Strengthening Oversight of Imported Drugs: Key... (9/18/2025)

Merger Control in China's Healthcare Industry:... (9/15/2025)

China Issues Guidance to Address Common ... (10/13/2025) China Introduces New Regulations to Gove... (10/13/2025) AviadoBio and UgeneX Enter Exclusive Opt... (10/13/2025) Huadao Bio Secures Over CNY 100M in Seri... (10/13/2025) Kelun-Biotech Presents Promising Phase 1... (10/13/2025) CF PharmaTech Soars 161% on Hong Kong IP... (10/13/2025) Eccogene Files for Hong Kong IPO (10/13/2025) Zenas Secures Global Rights to InnoCare'... (10/13/2025) 4B Technologies' Novel NGF Receptor Inhi... (10/13/2025) Hope Medicine Reports Positive Global Ph... (10/13/2025) Walgreens Boots Alliance Fully Exits Nan... (10/13/2025) Expedition Therapeutics Secures USD 165M... (10/13/2025) Chengdu NRT Raises ~CNY 800M in Series D... (10/13/2025) Micot Pharma Completes Over CNY 200M Ser... (10/13/2025) PegBio Signs Exclusive Licensing Term Sh... (10/13/2025) Kelun-Biotech Wins China Approval for TR... (10/13/2025) USB's Zilbrysq Wins Chinese Approval (10/13/2025) CSPC's Novel siRNA Therapy Gains U.S. Gr... (10/13/2025)

China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M... China Drives Asia-Pacific Health Care Transformation Am...

PegBio Signs Exclusive Licensing Term Sheet with UAE's ... Micot Pharma Completes Over CNY 200M Series D Financing... Chengdu NRT Raises ~CNY 800M in Series D Financing to A... Expedition Therapeutics Secures USD 165M in Oversubscri... Walgreens Boots Alliance Fully Exits Nanjing Pharma

China Introduces New Regulations to Govern Clinical Res... China Issues Guidance to Address Common Challenges in P... China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Over... China Issues Detailed Rules on Pre-Approval Import of O... CDE Seeks Public Input on Clinical Evaluation Guideline...

China Expands Medical Insurance Coverage for Rare Disea... China Unveils New Rules for 11th Round of National Cent... China Launches Pilot Program for Real-World Comprehensi... China to Incorporate HPV Vaccines into National Immuniz... NHSA Seeks Feedback on Draft Implementation Rules for M...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola... China's Sharp API Price Cuts Jeopardize India's Self-Re... China Produces Dozens of Drugs Below Market Price – U.... India Moves to Set Minimum Import Prices to Protect Pha...

CSPC's Novel siRNA Therapy Gains U.S. Green Light for C... USB's Zilbrysq Wins Chinese Approval Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR... Hope Medicine Reports Positive Global Phase 2 Results f... 4B Technologies' Novel NGF Receptor Inhibitor 4B03-04 R...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...